Novel, fluorescent, magnetic, polysaccharide-based microsphere for orientation, tracing, and anticoagulation: preparation and characterization.
A fluorescent, magnetic composite poly(styrene-maleic anhydride) microsphere, suitable for conjugation with polysaccharide, was synthesized using magnetite/europium phthalate particles as seeds by copolymerization of styrene and maleic anhydride. The magnetite/europium phthalate particles were wrapped up by poly(ethylene glycol), which improved the affinity between the seed particles and the monomers. The composite microspheres obtained, with a diameter of 0.15-0.7 microm, contain 586-1013 microg of magnetite/g of microsphere and 0.5-16 mmol surface anhydride groups/g of microsphere. Heparin was conjugated with the reactive surface anhydride groups on the surface of the microspheres by covalent binding to obtain a fluorescent, magnetic, polysaccharide-based microsphere. The microspheres not only retain their bioactivities but also provide magnetic susceptibility and fluorescence. They can be used as a carrier with magnetic orientation and fluorescence tracer for potent drug targeting. The orientation, tracer, and anticoagulation of the fluorescence, magnetic, polysaccharide-based microspheres were studied. The anticoagulant activity of the microspheres and heparin binding capacity reached 54,212.8 U and 607.1 mg/g of dry microspheres. The activity recovery was 50.2%. The anticoagulant activity of the microspheres increases with the increase of the conjugated heparin on the surface of the microspheres and the decrease of the microsphere size. Furthermore, The fluorescent, magnetic, polysaccharide-based microspheres can be easily transported to a given position in a magnetic field and traced via their fluorescence.
Qiu
Guang-Ming
GM
Department of Polymer Science & Engineering, Zhejiang University, Hangzhou, 310027, PR China.
Xu
You-Yi
YY
Zhu
Bao-Ku
BK
Qiu
Guang-Liang
GL
D000925:Anticoagulants / Q000008:administration & dosage*; D004337:Drug Carriers / Q000138:chemical synthesis* / Q000737:chemistry; D052203:Ferrosoferric Oxide; D005453:Fluorescence; D006493:Heparin / Q000008:administration & dosage / Q000737:chemistry; D007501:Iron; D008280:Magnetics; D008299:Maleic Anhydrides; D008863:Microspheres; D049329:Nanostructures; D010087:Oxides; D010795:Phthalic Acids; D011134:Polysaccharides / Q000138:chemical synthesis* / Q000737:chemistry; D011137:Polystyrenes / Q000138:chemical synthesis / Q000737:chemistry
D000925:Anticoagulants; D004337:Drug Carriers; D008299:Maleic Anhydrides; D010087:Oxides; D010795:Phthalic Acids; D011134:Polysaccharides; D011137:Polystyrenes; C032279:phthalic acid; D006493:Heparin; C025704:Styromal; D007501:Iron; D052203:Ferrosoferric Oxide